medline.ch Onkologie Gynäkologische Tumoren

	Constructing shared genetic architecture between bioavailable testosterone and luminal A breast cancer in female. Breast Cancer Song N, Yang K, Li Y. PMID: 40178748 [PubMed - as supplied by publisher]
	Effects of different mind-body exercises on quality of life and cancer-related fatigue in breast cancer survivors: a systematic review and network meta-analysis. J Cancer Surviv Pi P, Zeng L, Han Q, Han B, Wang Y. PMID: 40178706 [PubMed - as supplied by publisher]
	Pyrotinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (PERSIST): A multicenter phase II trial. Elife Cao F, Ma Z, Wu Z, Wu W, Wang O, Cui B, Zhu X, Hao J, Ji X, Li Z, Tao D, Feng Q, Lin W, Shi D, Shu J, Zhou J, Huang S. PMID: 40178527 [PubMed - in process]
	The impact of fat graft reconstructive surgery on prognosis in young women with breast cancer: a study from the French insurance databases. Plast Reconstr Surg Laas E, Gaillard T, Couturaud B, Darrigues L, Dumas E, Hamy AS, Feron JG, Reyal F, Husson F, Jannot AS. PMID: 40178525 [PubMed - as supplied by publisher]
	Cardiac MRI-based Subclinical Cardiac Dysfunction during 2 Years after Breast Cancer Irradiation: The MEDIRAD EARLY-HEART Study. Radiol Cardiothorac Imaging Lamy J, Spoor DS, Langendijk JA, Vliegenthart R, Eraso A, Ventura M, Constantino Rosa Santos S, Fiúza M, Kachenoura N, Crijns APG, Mousseaux E, MEDIRAD EARLY-HEART investigators. PMID: 40178396 [PubMed - in process]
	Key findings highlighted in the first annual cancer report from the American College of Surgeons: This report includes new observations and recent trends in cancer diagnoses as well as in-depth information on treatments and outcomes for breast, pancreatic, and colon cancers. Cancer Nierengarten MB. PMID: 40178124 [PubMed - in process]
	Increasing the Uptake of Breast and Cervical Cancer Screening Via the MAwar Application: Stakeholder-Driven Web Application Development Study. JMIR Form Res Nasrudin N, Sazlina SG, Cheong AT, Lee PY, Teo SH, Aneesa AR, Teo CH, Rokhani FZ, Haron NA, Harrun NH, Ho BK, Mohamed Isa S. PMID: 40177938 [PubMed - in process]
	Vepdegestrant for the treatment of HR+/HER2- breast cancer. Expert Opin Pharmacother Mukohara T. PMID: 40177927 [PubMed - as supplied by publisher]
	The estrobolome: Estrogen-metabolizing pathways of the gut microbiome and their relation to breast cancer. Int J Cancer Larnder AH, Manges AR, Murphy RA. PMID: 40177842 [PubMed - as supplied by publisher]
	Genomic Insights Into Early Relapsed Breast Cancer: Prognostic Challenges and Mutation Landscape. Onco Targets Ther Wang Y, Zhang L, Du Y, Yan T, Yang F, Yang Y, Liu B, Xie L. PMID: 40177613 [PubMed]
	Computational molecular insights into ibrutinib as a potent inhibitor of HER2-L755S mutant in breast cancer: gene expression studies, virtual screening, docking, and molecular dynamics analysis. Front Mol Biosci Loganathan T, George Priya Doss C. PMID: 40177517 [PubMed]
	Utility of photoacoustic patterns in intra-operative margin assessment of breast cancer post neoadjuvant chemotherapy. Photoacoustics Goh Y, Balasundaram G, Tan HM, Putti TC, Bi R, Hartman M, Buhari SA, Ng CWQ, Lui SA, Goh SSN, Leong WQ, Fang E, Quek ST, Olivo M. PMID: 40177367 [PubMed]
	Breast cancer in Cape Verde: a 24-year retrospective study of clinical presentation, treatment and outcomes at Agostinho Neto University Hospital. Ecancermedicalscience Borges P, Spencer HB, Furtado S, Costa V, Barbosa C, Santos LL. PMID: 40177147 [PubMed]
	Advances in research and current challenges in the treatment of advanced HER2-low breast cancer. Front Cell Dev Biol Qin Q. PMID: 40177129 [PubMed]
	In-silico study of rosmarinic acid roles in inhibiting breast cancer progression. Biomedicine (Taipei) Mahayana NPK, Dwi Sutanegara NBASNJ, Mahardana MDP, Wihandani DM. PMID: 40176865 [PubMed]
	Unveiling role of oncogenic signalling pathways in complicating breast cancer. Biomedicine (Taipei) Balkrishna A, Kumar S, Malik R, Mehra KS, Chaturvedi H, Okeshwar, Mittal R. PMID: 40176859 [PubMed]
	CircRNAs: a novel potential strategy to treat breast cancer. Front Immunol Chen P, Zhang J, Wu S, Zhang X, Zhou W, Guan Z, Tang H. PMID: 40176810 [PubMed - in process]
	MBNL2 enhances cisplatin resistance by regulating apoptosis in ovarian cancer cells. BMB Rep Sung HY, Han J, Ju W, Kang JL, Park AK, Ahn JH. PMID: 40176605 [PubMed - as supplied by publisher]
	Polyethyleneimine/gold nanorods conjugated with carbon quantum dots and hyaluronic acid for chemo-photothermal therapy of breast cancer. J Mater Chem B Khoshnood A, Farhadian N, Abnous K, Matin MM, Ziaee N, Iranpour S. PMID: 40176547 [PubMed - as supplied by publisher]
	Comparison of Machine Learning Models for Classification of Breast Cancer Risk Based on Clinical Data. Cancer Rep (Hoboken) Rafiepoor H, Ghorbankhanloo A, Zendehdel K, Madar ZZ, Hajivalizadeh S, Hasani Z, Sarmadi A, Amanpour-Gharaei B, Barati MA, Saadat M, Sadegh-Zadeh SA, Amanpour S. PMID: 40176498 [PubMed - in process]

Artikel 1 - 20 / 306283

Seite 1 von 15315

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung